Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06105476
Other study ID # FGF21-APA
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 20, 2023
Est. completion date March 31, 2024

Study information

Verified date November 2023
Source University of Copenhagen
Contact Stina Ramne
Phone +4535320230
Email stina.ramne@sund.ku.dk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aims of this study are two-fold. First to investigate the influence of protein on the FGF21 response induced by alcohol, and second to investigate the influence of retinol on FGF21 concentrations and the FGF21 response induced by alcohol. Exploratory, and in order to investigate mechanisms behind the potential influence on alcohol-induced FGF21 response from protein or retinol intake, plasma glucose, insulin, glucagon, ethanol, acetaldehyde, acetate, retinol, retinoic acid, as well as subjective rating of appetite, will be measured.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date March 31, 2024
Est. primary completion date March 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Informed consent - Healthy men and women - Age between 18 and 50 years - Body mass index (BMI) between 20 and 27 kg/m2 Exclusion Criteria: - Chronic diseases or significant health problems that are disruptive for participation in the study (as judged by the principal investigator/clinical responsible) - Use, currently or within the previous 3 months, of medication that has the potential of affecting any of the blood parameters assessed in the study (as judged by the investigators) - Blood donation within the last 3 months or during the study period - Regular smoking or other nicotine use (electronic cigarettes, gum, snus, etc.) or nicotine cessation within the past 3 months. - Currently dieting or having lost/gained a significant amount of weight (±3 kg) in the previous 3 months - Women who are pregnant, breast-feeding or have the intention of becoming pregnant during the study period - Food allergies or food intolerance relevant for the study (judged by the investigators) - Substance abuse (alcohol and/or drugs) within the last 12 months - Average weekly alcohol intake above the recommendations from the Danish Health and Medicines Authority (10 standard units per week) - Taking dietary supplements containing vitamin A during the past 3 months - Simultaneous participation in other clinical studies that can interfere with the current study - Inability, physically or mentally, to comply with the procedures required by the study protocol

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Alcohol
Test drink with 12 g alcohol (30 g vodka 40%) in water
Alcohol+protein
Test drink with 12 g alcohol (30 g vodka 40%) and 25 g whey protein in water
Alcohol+retinol
Test drink with 12 g alcohol (30 g vodka 40%) and 1000 µg retinol in water
Retinol
Test drink with 1000 µg retinol in water

Locations

Country Name City State
Denmark Departmen of Nutrition, Exercise and Sports Copenhagen

Sponsors (1)

Lead Sponsor Collaborator
University of Copenhagen

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Plasma FGF21 response after consumption of alcohol+protein vs alcohol Time*drink interaction and iAUC Outcomes are measured at time 0, 30, 60, 120, 180, and 240 minutes after test drinks.
Primary Plasma FGF21 response after consumption of alcohol+retinol vs alcohol vs retinol Time*drink interaction and iAUC Outcomes are measured at time 0, 30, 60, 120, 180, and 240 minutes after test drinks.
Secondary Plasma glucose, insulin, glucagon, ethanol, acetaldehyde, acetate, retinol, and retinoic acid after consumption of alcohol+protein vs alcohol+retinol vs alcohol vs retinol. Time*drink interaction and iAUC Outcomes are measured at time 0, 30, 60, 120, 180, and 240 minutes after test drinks.
Secondary Subjective appetite ratings after consumption of alcohol+protein vs alcohol+retinol vs alcohol vs retinol. Time*drink interaction and iAUC Outcomes are measured at time 0, 30, 60, 120, 180, and 240 minutes after test drinks.
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1